HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferguson, M. K. Articles by Skinner, D. B. Search for Related Content PubMed PubMed Citation Articles by Ferguson, M. K. Articles by Skinner, D. B.

The Journal of Thoracic and Cardiovascular Surgery, Vol 91, 344-349, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer

MK Ferguson, AG Little, HM Golomb, PC Hoffman, TR DeMeester, R Beveridge and DB Skinner

Thirty-four consecutive patients with non-small cell lung cancer plus N1 nodal metastases (eight with T1 N1 M0 and 26 with T2 N1 M0) were retrospectively reviewed. Nineteen had adenocarcinoma, 11 had squamous disease, and four had large cell carcinoma. Eleven patients had surgical resection alone (32.3%), with a median survival of 13 months. Seven patients (20.6%) had resection followed by radiation therapy, with a median survival of 19.2 months. Sixteen patients (47.1%) had resection followed by radiation therapy and chemotherapy, consisting of cyclophosphamide, doxorubicin, methotrexate, and procarbazine. Median survival for the latter group was 45.5 months, significantly greater than for those treated with resection alone (p less than 0.005). We did not observe any relationship between survival and age, cell type, number or location of diseased hilar nodes, distance of tumor from the resected bronchial margin, tumor size, the presence or absence of visceral pleural involvement, or the type of resection performed. Resection in combination with adjuvant radiation therapy and chemotherapy offers improved median survival over resection alone in patients with T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.

This article has been cited by other articles:

				O. A. Khan, J. J. Fitzgerald, M. L. Field, I. Soomro, F. D. Beggs, W. E. Morgan, and J. P. Duffy Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung Ann. Thorac. Surg., April 1, 2004; 77(4): 1173 - 1178. [Abstract] [Full Text] [PDF]

				A. Marra, L. Hillejan, G. Zaboura, T. Fujimoto, D. Greschuchna, and G. Stamatis Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 543 - 553. [Abstract] [Full Text] [PDF]

				F. Tanaka, K. Yanagihara, Y. Otake, T. Yamada, T. Shoji, R. Miyahara, K. Inui, and H. Wada Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC) Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 555 - 561. [Abstract] [Full Text] [PDF]

				J. H. Park, Y. M. Shim, H. J. Baek, M.-S. Kim, D. H. Choe, K.-J. Cho, C.-T. Lee, and J. I. Zo Postoperative adjuvant therapy for stage II non-small-cell lung cancer Ann. Thorac. Surg., November 1, 1999; 68(5): 1821 - 1826. [Abstract] [Full Text] [PDF]

				I. Yoshino, R. Nakanishi, T. Osaki, M. Takenoyama, S. Taga, T. Hanagiri, and K. Yasumoto Unfavorable Prognosis of Patients With Stage II Non-small Cell Lung Cancer Associated With Macroscopic Nodal Metastases Chest, July 1, 1999; 116(1): 144 - 149. [Abstract] [Full Text] [PDF]

				E. van Velzen, R. J. Snijder, A. B. de la Riviere, H. R. J. Elbers, and J. M. M. van den Bosch Lymph Node Type as a Prognostic Factor for Survival in T2 N1 M0 Non-Small Cell Lung Carcinoma Ann. Thorac. Surg., May 1, 1997; 63(5): 1436 - 1440. [Abstract] [Full Text]

				J. Olak and A. Ng Diagnosis and Treatment of Early-Stage Non-Small Cell Lung Cancer Oncologist, August 1, 1996; 1(4): 201 - 209. [Abstract] [Full Text] [PDF]

				T. Yano, H. Yokoyama, T. Inoue, H. Asoh, K. Tayama, and Y. Ichinose Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lungSignificance of N1 level: lobar or hilar nodes J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1398 - 1402. [Abstract] [Full Text]